Haruka Maruyama is a global public health professional with extensive experience managing large-scale public health programs and research in HIV/AIDS, with technical expertise in HIV prevention and care, community-based HIV services (CBHS), youth, key populations (KP), and population-based surveys.
Prior to this role, Ms. Maruyama was the project director for the Lesotho Population-Based HIV Impact Assessment (LePHIA2020), where she successfully led the planning and completion of data collection of this high-profile national survey, collaborating with Ministry of Health, CDC, and other partners. Between 2013 and 2019, she served ICAP in Tanzania as research advisor, senior technical advisor, and director of prevention services. During her previous tenure in Tanzania, she successfully guided a number of projects from design to implementation, including the Bukoba Combination Prevention Evaluation (BCPE) research project as well as the FIKIA Project, a five-year CDC PEPFAR-funded grant spearheading innovative community-based HIV service delivery for key and vulnerable populations. Prior to joining ICAP, she worked for the University of Texas Health Science Centre based in Dar es Salaam, Tanzania, managing a project delivering HIV outreach services including harm reduction services to key populations.
Ms. Maruyama holds a Master’s in Public Health (MPH) from the University of Texas Health Science Center at Houston and a Bachelor’s degree in African Studies from Rice University. She is currently pursuing a Doctorate in Public Health (DrPH) in implementation science at the Johns Hopkins Bloomberg School of Public Health.